Inside a surprise FDA rejection of a rare disease drug

Inside a surprise FDA rejection of a rare disease drug

statnews.com • • business

Key Points:

  • An experimental therapy for a rare blood cancer was on the path toward approval by the Food and Drug Administration last year — with internal reviewers recommending it be cleared — before the agency r

Trending Business

Trending Technology

Trending Health